Cite
HARVARD Citation
Le Page, E. et al. (2015). Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial. Lancet. 386 (9997), pp. 974-981. [Online].